Bilal Chughtai, MD
Dr. Bilal Chughtai, Chief of Urology at Plainview Hospital, completed his medical degree at Stony Brook University, followed by residency in urologic surgery at Albany Medical Center. He completed his fellowship in Male Voiding Dysfunction, Neuro-Urology, Female Pelvic Medicine Reconstructive Surgery at Memorial Sloan-Kettering Cancer Center and New York Presbyterian Hospital/Weill Cornell Medical College in New York City.
Dr. Chughtai specializes in Female Pelvic Medicine and Reconstructive Surgery and Male Voiding Dysfunction. He maintains a deep, longitudinal interest in these highly prevalent and debilitating conditions and has focused both his clinical, research, and teaching activities on these areas.
Dr. Chughtai's mentorship in clinical and basic science research projects has enabled his team to be investigators in numerous clinical trials, as well as translational, and outcomes research including National Institute of Health and industry support. He has authored over 300 peer-reviewed articles, chapters in urologic texts, 4 textbooks, and has presented extensively at national and international meetings.
Dr. Chughtai specializes in Female Pelvic Medicine and Reconstructive Surgery and Male Voiding Dysfunction. He maintains a deep, longitudinal interest in these highly prevalent and debilitating conditions and has focused both his clinical, research, and teaching activities on these areas.
Dr. Chughtai's mentorship in clinical and basic science research projects has enabled his team to be investigators in numerous clinical trials, as well as translational, and outcomes research including National Institute of Health and industry support. He has authored over 300 peer-reviewed articles, chapters in urologic texts, 4 textbooks, and has presented extensively at national and international meetings.
Financial relationships
-
Attribution:SelfType of financial relationship:Consultant or Advisor (General Urology)Ineligible company:MeditateDate added:Date updated:08/23/2024Relationship end date:01/01/2022
-
Attribution:SelfType of financial relationship:Meeting Participant or Lecturer (General Urology)Ineligible company:AllerganDate added:Date updated:08/23/2024Relationship end date:01/01/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (General Urology)Ineligible company:MedeonBioDate added:Date updated:08/23/2024
-
Attribution:SelfType of financial relationship:Consultant or Advisor (General Urology)Ineligible company:OlympusDate added:Date updated:08/23/2024
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:Boston ScientificDate added:Date updated:08/23/2024